Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsGlenmarkpharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Better to book profit in mid-caps that have rallied 20-30% from recent lows: Axis Securities

      He expect Nifty to trade in the range of 11,600-11,420 with mixed bias.

    • Nifty may move toward 11,700; positive on TCS, RIL, ONGC, Glenmark

      India VIX fell down by 5.70 percent at 12.41 and lower volatility even after small dips suggests the declines in the market could be bought.

    • Value emerging after destruction in midcaps, smallcaps; top 2 stocks that can give 20% returns

      Akash Jain of Ajcon Global said after the massive destruction in midcaps and smallcaps, one can consider companies in midcaps and smallcaps space wherein FY18 earnings have been strong in sunrise sectors backed by ethical management.

    • Positive momentum in market to continue; 4 midcaps, 1 largecap that can return 14-20%

      The relative strength index (RSI) is trading near 66 levels, which indicates positive momentum and support for the bullish rally

    • Buy Glenmark Pharma, target Rs 652: Hadrien Mendonca

      We expect the stock to move higher and every long position should be protected with a stop loss below Rs 579 on a closing basis, says Hadrien Mendonca of IIFL.

    • Podcast | Stock Picks of the Day: 3 midcap buys that could return 9%

      Hadrien Mendonca of IIFL said it will be in the interest of traders to remain stock specific at the current juncture.

    • Buy or sell: Top stock trading ideas by market experts which are good short term bets

      Rajesh Agarwal of AUM Capital recommends buying HPCL with stop loss at Rs 309 and target of Rs 323, Apollo Tyres with stop loss at Rs 269 and target of Rs 282 and Vedanta with stop loss at Rs 224 and target of Rs 236.

    • Buy or sell: Top stock trading ideas by market experts which are good short term bets

      Vinay Rajani of HDFC Securities recommends buying United Breweries with target at Rs 1,370 and stop loss at Rs 1230 and Tata Elxsi with target at Rs 1,390 and stop loss at Rs 1,240.

    • Nifty to trade in a 10,800-10,880 range today; stay cautious on every rise

      “Considering the broader market trend, we prefer a buy on dips,” says Jaydeb Dey of Stewart & Mackertich Wealth Management

    • Q4 review: Foreign brokerages are betting on these top 10 stocks

      “The Beats-to-misses (BTM) ratio for 4Q was 0.76x indicating that there were more misses than beats this quarter. After the largely positive surprises in 2Q which had a BTM of 1.42x, 3Q and 4Q have witnessed a sequential decline,” JM Financial said in a report.

    • Top 10 stocks below Rs 1,000 which could deliver up to 17% return in the short-term

      Here is a list of top 10 ideas priced less than Rs 1,000 which can deliver up to 17% return in the short-term.

    • Nifty could see pressure at higher levels; Top six stocks which are looking attractive

      "There has been a sharp upside bounce in Nifty in the last three weeks, but this is going to be a temporary trading bounce"

    • Hold Glenmark Pharma, advises Sumit Bilgaiyan

      " I would hold on to this stock and in terms of valuation it is not expensive. Some recovery from lower levels is expected and target is Rs 590 in the near term," says Sumit Bilgaiyan, Founder of Equity99.

    • Bull's Eye: Buy Titan, Bank of India, Glenmark, Pidilite, Indian Bank, Wockhardt

      Ruchit Jain of Angel Broking is of the view that one may buy Glenmark Pharma with a target of Rs 585.

    • Stay invested in Glenmark Pharma: Shahina Mukadam

      According to Shahina Mukadam, Independent Market Expert, one may stay invested in Glenmark Pharma.

    • Exit Glenmark Pharma, says Sandeep Wagle

      Sandeep Wagle of powermywealth.com suggests exiting Glenmark Pharma.

    • Buy Jubilant Foodworks, Kajaria Ceramics; sell Glenmark Pharma, UltraTech Cement: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com is of the view that one can buy Jubilant Foodworks and Kajaria Ceramics and can sell Glenmark Pharma and UltraTech Cement.

    • Bull's Eye: Buy Jet Airways, MCX India, SAIL, Coal India; sell Glenmark

      Vijay Chopra of enochventures.com suggests buying Hindusthan Zinc with a target of Rs 310.

    • Bull's Eye: Buy Lupin, Bank of Baroda, IFCI, Glenmark, Godrej Consumer, Amara Raja

      Rakesh Bansal of RK Global is of the view that one may buy Bank of Baroda with a target of Rs 183.

    • Sell Power Grid; buy Hexaware, Amara Raja Batteries: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may buy Hexaware and Amara Raja Batteries.

    • Buy Glenmark Pharma, sell Ujjivan Financial Services: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one can buy Glenmark Pharma and can sell Ujjivan Financial Services.

    • Buy Glenmark Pharma, Jain Irrigation Systems; sell Biocon: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Glenmark Pharma and Jain Irrigation Systems and can sell Biocon.

    • Buy Reliance Industries, Torrent Power, Strides Shasun; sell Union Bank of India: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Reliance Industries, Torrent Power and Strides Shasun and can sell Union Bank of India.

    • Remain invested in Glenmark Pharma: Avinnash Gorakssakar

      Avinnash Gorakssakar, Market Expert is of the view that one may remain invested in Glenmark Pharma.

    • Hold Glenmark Pharma, says Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one may hold Glenmark Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347